“We are not just able to create a business; we are able to create a success”
The new foreign owners of the State Serum Institute’s vaccine production have big plans for an expansion of the Danish business. New employees, new markets, and new products are on the agenda for AJ Vaccines A/S, which is headed by a former senior partner from NNE Pharmaplan.
BY STEFAN SINGH KAILAY
This week, Denmark officially waved goodbye to a state-owned vaccine production, as the State Serum Institute (SSI) completed the sale of its vaccine division to AJ Pharma, a part of Saudi conglomerate Aljomiah.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Danish biotech partners with Saudi company
For abonnenter
